Experimental diabetes in the rat causes an insulin-reversible decrease in renal 25-hydroxyvitamin D3-1 alpha-hydroxylase activity.
D015090:25-Hydroxyvitamin D3 1-alpha-Hydroxylase / Q000378:metabolism*; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001806:Blood Urea Nitrogen; D002117:Calcitriol; D002762:Cholecalciferol / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology*; D004100:Dihydroxycholecalciferols / Q000097:blood; D007328:Insulin / Q000494:pharmacology*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000378:metabolism; D007668:Kidney / Q000187:drug effects / Q000201:enzymology*; D007700:Kinetics; D008297:Male; D051381:Rats; D013250:Steroid Hydroxylases / Q000378:metabolism*
D001786:Blood Glucose; D004100:Dihydroxycholecalciferols; D007328:Insulin; D002762:Cholecalciferol; D013250:Steroid Hydroxylases; D015090:25-Hydroxyvitamin D3 1-alpha-Hydroxylase; D002117:Calcitriol